DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,121,000 | -33.2% | 204,430 | +23.7% | 0.01% | -41.2% |
| Q2 2021 | $6,168,000 | +64.6% | 165,251 | +12.7% | 0.02% | +30.8% |
| Q1 2021 | $3,748,000 | +112.2% | 146,587 | +82.9% | 0.01% | +85.7% |
| Q4 2020 | $1,766,000 | +69.8% | 80,155 | +38.7% | 0.01% | +40.0% |
| Q3 2020 | $1,040,000 | +3.1% | 57,804 | +45.5% | 0.01% | -16.7% |
| Q2 2020 | $1,009,000 | +151.6% | 39,715 | +82.1% | 0.01% | +100.0% |
| Q1 2020 | $401,000 | -6.3% | 21,805 | +12.2% | 0.00% | 0.0% |
| Q4 2019 | $428,000 | +83.7% | 19,442 | +20.1% | 0.00% | +50.0% |
| Q3 2019 | $233,000 | – | 16,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |